4.5 (148) In stock
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial - The Lancet Respiratory Medicine
Roberto TONELLI, Professor (Assistant), MD PhD
Anna SAMARELLI Università degli Studi di Modena e Reggio Emilia
Molecular Mechanisms from Lung Fibrosis to Lung Cancer
Core fucosylation regulates alveolar epithelial cells senescence through activating of transforming growth factor-β pathway in pulmonary fibrosis
Percentage of environmental exposure among studied patients with
Potential role of biopeptides in the treatment of idiopathic pulmonary fibrosis - ScienceDirect
Proceedings of the ISCT scientific signature series symposium, “Advances in cell and gene therapies for lung diseases and critical illnesses” - Cytotherapy
Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis
Stem Cell Therapy for Aphasia - A New Approach
Comparison of survival probabilities of IPF patients with and without
PDF) Molecular Mechanisms and Cellular Contribution from Lung
Demographic data of the two dead patients during our study
Massimo DOMINICI Università degli Studi di Modena e Reggio
